Literature DB >> 8226771

C-terminal processing of human beta-glucuronidase. The propeptide is required for full expression of catalytic activity, intracellular retention, and proper phosphorylation.

M R Islam1, J H Grubb, W S Sly.   

Abstract

beta-Glucuronidase undergoes proteolytic C-terminal processing during or after its transport to lysosomes or endosomes. We determined the C-terminal processing site for human placental beta-glucuronidase to be the peptide bond between Thr633-Arg634. To evaluate the role of the 18-amino acid peptide removed in C-terminal processing, we changed the codon for Arg634 to a stop codon by site-directed mutagenesis and studied expression of the truncated mutant enzyme in COS-7 cells. An increased fraction of newly synthesized enzyme from R634Stop cDNA was secreted. Pulse-chase experiments provided no evidence for increased degradation of the intracellular R634Stop enzyme. The total amount of catalytic activity expressed from the R634Stop mutant cDNA was only half that seen with the wild type cDNA, and the Kcat of the mutant enzyme was 52% that of wild type enzyme. These results indicate that the C-terminal propeptide in the precursor is important for beta-glucuronidase to achieve maximal activity. The truncated enzyme formed hybrid tetramers in cotransfection experiments with the cDNA for rat beta-glucuronidase. There appeared to be no decrease in stability of the R634Stop enzyme, since chaotropic agents, heat treatment, and pH had similar effects on the mutant and the wild type enzymes. The uptake rate of the truncated mutant (R634Stop) enzyme by beta-glucuronidase-deficient human fibroblast cells was only 55-60% that of the wild type enzyme. Binding to the immobilized cation-independent mannose-6-phosphate receptor and measurement of the 32P-labeled phosphorylated oligosaccharides revealed that the truncated mutant enzyme was 32-34% less phosphorylated and appeared to contain proportionately more covered phosphate groups than the wild type enzyme. These results suggest that the propeptide influences the accessibility to both processing enzymes that produce the mannose-6-phosphate recognition marker on beta-glucuronidase.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8226771

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  The role of beta-glucuronidase in drug disposition and drug targeting in humans.

Authors:  B Sperker; J T Backman; H K Kroemer
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

2.  Annexin-directed β-glucuronidase for the targeted treatment of solid tumors.

Authors:  Katrin P Guillen; Eliza A Ruben; Needa Virani; Roger G Harrison
Journal:  Protein Eng Des Sel       Date:  2016-12-15       Impact factor: 1.650

3.  Structure-based design, synthesis and biological evaluation of β-glucuronidase inhibitors.

Authors:  Khalid M Khan; Nida Ambreen; Muhammad Taha; Sobia A Halim; Shagufta Naureen; Saima Rasheed; Shahnaz Perveen; Sajjad Ali; Mohammad Iqbal Choudhary
Journal:  J Comput Aided Mol Des       Date:  2014-04-27       Impact factor: 3.686

4.  Activity-based probes for functional interrogation of retaining β-glucuronidases.

Authors:  Liang Wu; Jianbing Jiang; Yi Jin; Wouter W Kallemeijn; Chi-Lin Kuo; Marta Artola; Wei Dai; Cas van Elk; Marco van Eijk; Gijsbert A van der Marel; Jeroen D C Codée; Bogdan I Florea; Johannes M F G Aerts; Herman S Overkleeft; Gideon J Davies
Journal:  Nat Chem Biol       Date:  2017-06-05       Impact factor: 15.040

5.  Molecular analysis of patients with beta-glucuronidase deficiency presenting as hydrops fetalis or as early mucopolysaccharidosis VII.

Authors:  R Vervoort; M R Islam; W S Sly; M T Zabot; W J Kleijer; A Chabas; A Fensom; E P Young; I Liebaers; W Lissens
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

6.  Glycosylation-independent targeting enhances enzyme delivery to lysosomes and decreases storage in mucopolysaccharidosis type VII mice.

Authors:  Jonathan H LeBowitz; Jeffrey H Grubb; John A Maga; Deborah H Schmiel; Carole Vogler; William S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-19       Impact factor: 11.205

7.  Biochemical properties of recombinant human beta-glucuronidase synthesized in baby hamster kidney cells.

Authors:  M C Gehrmann; M Opper; H H Sedlacek; K Bosslet; J Czech
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

8.  The ctpA gene encodes the C-terminal processing protease for the D1 protein of the photosystem II reaction center complex.

Authors:  P R Anbudurai; T S Mor; I Ohad; S V Shestakov; H B Pakrasi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

9.  A pseudodeficiency allele (D152N) of the human beta-glucuronidase gene.

Authors:  R Vervoort; M R Islam; W Sly; A Chabas; R Wevers; J de Jong; I Liebaers; W Lissens
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025

10.  Infused Fc-tagged beta-glucuronidase crosses the placenta and produces clearance of storage in utero in mucopolysaccharidosis VII mice.

Authors:  Jeffrey H Grubb; Carole Vogler; Yun Tan; Gul N Shah; Amy F MacRae; William S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.